ReviewCancer communications (London, England)2026
Spatiotemporal Analysis of Molecular Continuity in Pathogenesis of Squamous Cell Carcinoma: From Normal Epithelium to Precancerous Lesions and Carcinoma.
Review in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squamous cell carcinomas (SCCs) develop from the stratified epithelia of the esophagus, head and neck, lung, and skin, providing a tractable model to investigate how altered epithelial fields progress toward invasive cancer. Across SCC subtypes, evolution often begins before overt malignancy, with age- and exposure-associated mutant clones expanding within histologically normal epithelia. As lesions advance, early driver selection becomes coupled to copy number alterations, chromosomal instability, and epigenetic remodeling, whereas later stages are shaped by branching diversification, cellular plasticity, and regionally constrained selection. Despite tissue-specific differences, several recurrent principles emerge, including clonal expansion within mutated normal fields, transition bottlenecks marked by genome-scale instability, and the spatial organization of subclonal architecture and invasive-front states. In this review, we synthesize recent progress in the temporal ordering and spatial patterning of SCC evolution and discuss how genetic alterations, epigenetic remodeling, and tissue ecology jointly drive disease progression. We further highlight the implications for early interception, biomarker development, immune evasion, and evolution-informed prevention and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.